Cargando…
mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771617/ https://www.ncbi.nlm.nih.gov/pubmed/35050384 http://dx.doi.org/10.1007/s00134-021-06610-z |
| _version_ | 1784635648012976128 |
|---|---|
| author | Hilty, Matthias Peter Keiser, Stefanie Wendel Garcia, Pedro D. Moser, André Schuepbach, Reto A. |
| author_facet | Hilty, Matthias Peter Keiser, Stefanie Wendel Garcia, Pedro D. Moser, André Schuepbach, Reto A. |
| author_sort | Hilty, Matthias Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8771617 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87716172022-01-20 mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland Hilty, Matthias Peter Keiser, Stefanie Wendel Garcia, Pedro D. Moser, André Schuepbach, Reto A. Intensive Care Med Letter Springer Berlin Heidelberg 2022-01-20 2022 /pmc/articles/PMC8771617/ /pubmed/35050384 http://dx.doi.org/10.1007/s00134-021-06610-z Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter Hilty, Matthias Peter Keiser, Stefanie Wendel Garcia, Pedro D. Moser, André Schuepbach, Reto A. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland |
| title | mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland |
| title_full | mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland |
| title_fullStr | mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland |
| title_full_unstemmed | mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland |
| title_short | mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland |
| title_sort | mrna-based sars-cov-2 vaccination is associated with reduced icu admission rate and disease severity in critically ill covid-19 patients treated in switzerland |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771617/ https://www.ncbi.nlm.nih.gov/pubmed/35050384 http://dx.doi.org/10.1007/s00134-021-06610-z |
| work_keys_str_mv | AT hiltymatthiaspeter mrnabasedsarscov2vaccinationisassociatedwithreducedicuadmissionrateanddiseaseseverityincriticallyillcovid19patientstreatedinswitzerland AT keiserstefanie mrnabasedsarscov2vaccinationisassociatedwithreducedicuadmissionrateanddiseaseseverityincriticallyillcovid19patientstreatedinswitzerland AT wendelgarciapedrod mrnabasedsarscov2vaccinationisassociatedwithreducedicuadmissionrateanddiseaseseverityincriticallyillcovid19patientstreatedinswitzerland AT moserandre mrnabasedsarscov2vaccinationisassociatedwithreducedicuadmissionrateanddiseaseseverityincriticallyillcovid19patientstreatedinswitzerland AT schuepbachretoa mrnabasedsarscov2vaccinationisassociatedwithreducedicuadmissionrateanddiseaseseverityincriticallyillcovid19patientstreatedinswitzerland AT mrnabasedsarscov2vaccinationisassociatedwithreducedicuadmissionrateanddiseaseseverityincriticallyillcovid19patientstreatedinswitzerland |